joe iniowa
@Microcapreturns
Long time investor, retired from tech space
You might like
$GANX Gain Therapeutics At the 52.40 mark of yesterday's Sachs conf. CEO says we are getting biomarker correlation we have been waiting data on. youtu.be/Hvsllm583Vc?si…
youtube.com
YouTube
Progress in PD & Movement Disorders Panel @ Sachs_NIF
Gain Therapeutics $GANX GT-02287 showing efficacy after only 90 days in phase 1b.
Drugging GCase: The Challenges With Targeting A Multi-Compartment Enzyme | drughunters.com/3OeJgqD GCase (encoded by GBA1) is a pivotal genetic risk factor in Parkinson’s and Gaucher’s diseases, where folding/trafficking defects disrupt lysosomal lipid metabolism and drive
From opening new therapeutic mechanisms to repairing neuronal damage, investigational molecules from Ventyx Therapeutics, AC Immune, Gain Therapeutics and more could shape the future of Parkinson’s disease treatment. #parkinsons #pharma #biospace hubs.li/Q040hgLC0
$GANX Gain Therapeutics At some point people are going to figure out exactly how valuable their ability to not only stop Parkinson's but reverse it. reddit.com/r/pennystocks/…
$GANX Gain Therapeutics. Busy last week including being part of panel with M.J. Fox Foundation. Return of smell, gait and balance in patients. Data getting out. Gain Therapeutics(GANX): KOL Reports : GT-02287 Shows Signs of Disease Modification gaintherapeutics.wordpress.com/2026/01/14/gai…
$GANX Gain Therapeutics in Parkinsons News Today Early trial data suggest GT-02287 may aid Parkinson’s symptoms parkinsonsnewstoday.com/news/early-tri…
$GANX Gain Therapeutics. Looking at data SAA must be improving if getting return of smell, gait and balance. reddit.com/r/pennystocks/…
reddit.com
From the pennystocks community on Reddit
Explore this post and more from the pennystocks community
$GANX Gain Therapeutics Amazing GluSph response and improvement in UPDRS data in 90 days.
Prediction Payoff: Ventyx Acquired, Plus Updates On Entera & Gain $VTYX $ENTX $GANX $ZVSA. Please note: Gain did in fact release patient-level data at the back end of its webinar slide deck (slide 32). Our mistake... encodelp.com/coverage-unive…
![encodelp's tweet card. In our last note, we made some fun predictions for a number of companies in our eclectic universe. Of all the predictions, the one that made us the most nervous […]](https://pbs.twimg.com/card_img/2023851118497763328/lGcZ1XSo?format=jpg&name=orig)
$GANX Improvement in smell, gait and balance after only the first 90 days.
$GANX Highlights Biomarker Evidence Supporting Disease-Modifying Potential of GT-02287 for Parkinson’s Disease. Hosting KOL call today too. lifescievents.com/event/sw9cp0z/
$GANX Gain Therapeutics KOL event with Phase 1b Parkinsons data next Tuesday.
What Gaucher’s disease can teach us about Parkinson’s in light of GT-02287 reducing GluSph by 75-95% $GANX Warning: skip if you don't like long posts One thing that really helps put the recent GT-02287 GluSph data in context is looking at it through the lens of Gaucher’s
What Gaucher’s disease can teach us about Parkinson’s in light of GT-02287 reducing GluSph by 75-95% $GANX Warning: skip if you don't like long posts One thing that really helps put the recent GT-02287 GluSph data in context is looking at it through the lens of Gaucher’s
$GANX Gain Therapeutics. Gauchers connection brings in companies like Sanofi and Pfizer into the mix. The GluSph biomarker is recognized by FDA for Gaucher trials. reddit.com/r/pennystocks/…
$GANX Gain Therapeutics. Final update before January 6th KOL event. Signup available along with ability to ask questions. Gain Therapeutics(GANX): Final Update before Phase 1b data at January 6th KOL Event gaintherapeutics.wordpress.com/2025/12/31/gai…
$GANX Gain Therapeutics Great to see scientific community explaining significance of Gains Phase 1b Parkinson's success. reddit.com/r/pennystocks/…
$GANX Gain Therapeutics KOL event next week. reddit.com/r/pennystocks/…
$GANX Gain Therapeutics About 5 trading days before KOL event on January 6th. Gain Therapeutics(GANX): Final countdown to Phase 1b data at January 6th KOL Event gaintherapeutics.wordpress.com/2025/12/20/gai…
$GANX GT-02287 boosts enzyme activity in Parkinson’s brain: Trial data Developer Gain Therapeutics to review results in January webinar parkinsonsnewstoday.com/news/gt-02287-…
$GANX Gain Therapeutics recent article the follow up data will be presented at AD/PD which means KOL event will be data we expected last week. we look forward to presenting longer follow-up from the study at the AD/PD™ conference in March 2026 neurologylive.com/view/brain-pen…
$GANX expect data at KOL event. Gain Therapeutics(GANX): Final countdown to Phase 1b data at January 6th KOL Event gaintherapeutics.wordpress.com/2025/12/20/gai…
$GANX with data coming at KOL event on January 6th. reddit.com/r/10xPennyStoc…
reddit.com
From the 10xPennyStocks community on Reddit: $GANX Gain Therapeutics: Final countdown to Phase 1b...
Explore this post and more from the 10xPennyStocks community
$GANX: From LULD Halts to a +27% Recovery! Is $3.61 Next? 📊⚡ Stop watching the headlines and look at the tape! $GANX just printed a textbook Wave (a) bottom at $2.14 and is charging back into Wave (b) territory. Friday’s 12M volume spike confirms the smart money is buying the
United States Trends
- 1. Tourette N/A
- 2. Kash N/A
- 3. Lakers N/A
- 4. Pritchard N/A
- 5. #RHOP N/A
- 6. Celtics N/A
- 7. FBI Director N/A
- 8. #BaddiesUSA N/A
- 9. #married2med N/A
- 10. #IndustryHBO N/A
- 11. El Mencho N/A
- 12. #90DayFiance N/A
- 13. Canadians N/A
- 14. Luka N/A
- 15. Jassi N/A
- 16. Pat Riley N/A
- 17. Puerto Vallarta N/A
- 18. México N/A
- 19. Chelsea Gray N/A
- 20. Cartel N/A
You might like
-
7investing
@7investing -
David Marlin
@Marlin_Capital -
Jason Assad
@AssadJason -
Danny Vena
@dannyvena -
Matthew Cochrane
@TheMattCochrane -
Marty Chargin
@MartyChargin -
BahamaBen
@BahamaBen9 -
Dhaval Kotecha
@dhaval_kotecha -
Rock Bottom Entries
@RockBtmEntries -
Parrot 🦜
@ParrotStock -
Paul Essen
@paul_essen -
Brad Schulz
@Brad_E_Schulz -
Leif Soreide
@LeifSoreide -
TerraPharma
@TerraPharma1 -
Money Mark
@MoneyMarkStocks
Something went wrong.
Something went wrong.